Back

The IRE1α-endonuclease regulates PD-1 expression through a novel XBP1/miRNA-34a axis within Natural Killer cells

Bednarska, K.; Thillaiyampalam, G.; Mujaj, S.; Nourse, J.; Gunawardana, J.; Sabdia, M. B.; Cui, Q.; de Long, L. M.; Vari, F.; Gandhi, M. K.; Cristino, A. S.

2023-02-27 cancer biology
10.1101/2023.02.26.530063 bioRxiv
Show abstract

Activation of the IRE1-endonuclease is critical for Natural Killer (NK)-cell function. We describe a novel regulatory role for IRE1-endonuclease in fine-tuning NK-cell effector functions through an inter-connected activation of the transcription factor XBP1s and inhibition of microRNA-34a-5p (miR-34a-5p) to modulate PD-1 immune checkpoint expression. NK-cells, when exposed to cancer cells, activate IRE1-endonuclease mediated decay of miR-34a-5p. This reduces miR-34a-5p and consequently increases the expression of the target genes XBP1 and PD-1. IRE1-endonuclease activation not only enhances NK-cell effector function but also promotes PD-1 expression. PD-1 is itself directly regulated by miR-34a-5p, which binds to the 3UTR of PD-1 messenger RNA to repress PD-1 protein at the NK-cell surface. IRE1-pathway activation is impaired in the NK-cells of patients with Hodgkin Lymphoma, and miR-34a-5p and PD-1 expression are inversely correlated. The IRE1-pathway plays a dual role in regulating the XBP1/miRNA-34a axis and PD-1 expression within NK-cells, that is disrupted in cancer patients.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.